Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Clin |
RCV003165363 | SCV003853564 | benign | CDKL5 disorder | 2023-02-20 | reviewed by expert panel | curation | The allele frequency of the p.Asn748Ser variant in CDKL5 is 0.03683% in African/African American sub population in gnomAD, which is high enough to be classified as benign based on thresholds defined by the ClinGen Rett/Angelman-like Expert Panel for Rett/AS-like conditions (BA1). The p.Asn748Ser variant is observed in at least 1 unaffected individual (PMID: 29264392) (BS2_supporting). In summary, the p.Asn748Ser variant in CDKL5 is classified as Benign based on the ACMG/AMP criteria (BA1, BA2_supporting). |
Eurofins Ntd Llc |
RCV000174879 | SCV000226272 | uncertain significance | not provided | 2014-05-26 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV000764870 | SCV000896026 | uncertain significance | Developmental and epileptic encephalopathy, 2 | 2018-10-31 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001512607 | SCV001720052 | benign | Developmental and epileptic encephalopathy, 2; Angelman syndrome-like | 2024-12-10 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000174879 | SCV001768120 | likely benign | not provided | 2020-12-09 | criteria provided, single submitter | clinical testing | Missense variant in a gene in which most reported pathogenic variants are truncating/loss-of-function; In silico analysis supports that this missense variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 29264392) |